Cargando…
Phosphodiesterase-5 Inhibition Alleviates Pulmonary Hypertension and Basal Lamina Thickening in Rats Challenged by Chronic Hypoxia
Background: Hypoxia represents both an outcome of cardiopulmonary diseases and a trigger for severe pulmonary complications as pulmonary hypertension. Because nitric oxide (NO) is a critical mediator in the development of pulmonary hypertension, the modulators of its downstream function may become t...
Autores principales: | Nydegger, Coline, Martinelli, Carla, Di Marco, Fabiano, Bulfamante, Gaetano, von Segesser, Ludwig, Tozzi, Piergiorgio, Samaja, Michele, Milano, Giuseppina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880920/ https://www.ncbi.nlm.nih.gov/pubmed/29636700 http://dx.doi.org/10.3389/fphys.2018.00289 |
Ejemplares similares
-
Effects of PDE-5 Inhibition on the Cardiopulmonary System After 2 or 4 Weeks of Chronic Hypoxia
por: Nydegger, Coline, et al.
Publicado: (2019) -
Nitric Oxide–cGMP Pathway Modulation in an Experimental Model of Hypoxic Pulmonary Hypertension
por: Reinero, Melanie, et al.
Publicado: (2021) -
Phosphodiesterase-5 Inhibition Mimics Intermittent Reoxygenation and Improves Cardioprotection in the Hypoxic Myocardium
por: Milano, Giuseppina, et al.
Publicado: (2011) -
Correction: Phosphodiesterase-5 Inhibition Mimics Intermittent Reoxygenation and Improves Cardioprotection in the Hypoxic Myocardium
por: Milano, Giuseppina, et al.
Publicado: (2012) -
Adaptation to Hypoxia: A Chimera?
por: Samaja, Michele, et al.
Publicado: (2020)